+499.5%
MRNA vs LYB
+25.6%
+473.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LYB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.9% | -0.3% | -2.2% |
| 7D | +5.5% | -0.2% | +5.7% | +5.5% |
| 30D | +158.7% | +8.7% | +150.0% | +159.4% |
| 3M | +182.1% | -3.0% | +185.2% | +185.1% |
| 6M | +151.8% | +4.7% | +147.1% | +143.8% |
| YTD | +393.6% | +51.6% | +342.0% | +338.1% |
| 1Y | +499.5% | +24.4% | +475.1% | +472.7% |
| All | +499.5% | +25.6% | +473.8% | +472.7% |
Cumulative growth
Daily Returns
Daily percentage return beside LYB.
Daily Out/Under-Performance
Portfolio return minus LYB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LYB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LYB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling